SCI TRANSL MED 润色咨询

Science Translational Medicine

出版年份:2009 年文章数:3041 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:0.9% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2016-03-11 Moke8966

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2016-01-30 RGBY

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2015-06-24 刘洋1981

    楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2015-05-26 lao6

    屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2014-04-27 mamingyang

    审稿速度:2.0
    经验分享:分数暴涨呀

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2013-04-09 匿名用户

    投了1篇,3周了,还没有拒,期望好消息。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2012-03-02 ms1706975392724364

    很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=520095, encodeId=fced5200955d, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享:一周拒稿,没有外审,可能高度不够,或者和学校也有关系, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=855, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/01/07/992397a31de8fe085a03a096beddda25.jpg, createdBy=9a581635059, createdName=Moke8966, createdTime=Fri Mar 11 13:03:00 CST 2016, time=2016-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=518894, encodeId=8276518894f5, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享:前年被拒了一个,今年中了一个,感觉很难。两篇文章之前都投过science,拒稿后,编辑建议转投Science Advance,并没有建议转至STM,感觉上这个期刊根本不像是拣剩儿的那种。整个投稿编辑过程与Science相差不大。另外,目前STM的接收率仅8%,可见一斑。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=77231684837, createdName=RGBY, createdTime=Sat Jan 30 03:33:00 CST 2016, time=2016-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512938, encodeId=c2ad51293837, content=楼下是逗逼吗?呵呵,还投一下试试……这个杂志不是收垃圾文章的杂志,IF15的水平!!!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=447, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200608/69dd05c9fcfa4768838a5589b5b25dd6/e3def69d3a5a45e8b6b33e44bf34132b.jpg, createdBy=8b9295286, createdName=刘洋1981, createdTime=Wed Jun 24 16:11:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=512101, encodeId=f28951210120, content=屡投屡拒,屡战屡败!屡拒屡投,屡败屡战!投了N个杂志了!还没被送审,投下这个试试!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=489, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d0c51611649, createdName=lao6, createdTime=Tue May 26 20:17:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502595, encodeId=46fe502595e1, content=审稿速度:2.0<br>经验分享:分数暴涨呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=624, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=37b874686, createdName=mamingyang, createdTime=Sun Apr 27 12:05:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=494938, encodeId=e77849493824, content=投了1篇,3周了,还没有拒,期望好消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=556, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue Apr 09 09:59:00 CST 2013, time=2013-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=818332, encodeId=fd0a818332d9, content=很牛,投转化医学的内容,直接被拒,明显不是3点几的杂志的要求 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bf45414128, createdName=ms1706975392724364, createdTime=Fri Mar 02 19:18:00 CST 2012, time=2012-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481286, encodeId=c090481286cb, content=看涨哦,如果明天再升一升,有望突破3分, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=693, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:50:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]
    2011-06-29 medwu

    看涨哦,如果明天再升一升,有望突破3分

    0

共92条页码: 5/10页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分